Literature DB >> 10195162

Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats.

L Studer1, V Tabar, R D McKay.   

Abstract

In vitro expansion of central nervous system (CNS) precursors might overcome the limited availability of dopaminergic neurons in transplantation for Parkinson's disease, but generating dopaminergic neurons from in vitro dividing precursors has proven difficult. Here a three-dimensional cell differentiation system was used to convert precursor cells derived from E12 rat ventral mesencephalon into dopaminergic neurons. We demonstrate that CNS precursor cell populations expanded in vitro can efficiently differentiate into dopaminergic neurons, survive intrastriatal transplantation and induce functional recovery in hemiparkinsonian rats. The numerical expansion of primary CNS precursor cells is a new approach that could improve both the ethical and the technical outlook for the use of human fetal tissue in clinical transplantation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10195162     DOI: 10.1038/1105

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  81 in total

1.  Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model.

Authors:  Lars M Bjorklund; Rosario Sánchez-Pernaute; Sangmi Chung; Therese Andersson; Iris Yin Ching Chen; Kevin St P McNaught; Anna-Liisa Brownell; Bruce G Jenkins; Claes Wahlestedt; Kwang-Soo Kim; Ole Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

2.  Sequential actions of BMP receptors control neural precursor cell production and fate.

Authors:  D M Panchision; J M Pickel; L Studer; S H Lee; P A Turner; T G Hazel; R D McKay
Journal:  Genes Dev       Date:  2001-08-15       Impact factor: 11.361

3.  Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons.

Authors:  K Sawamoto; N Nakao; K Kobayashi; N Matsushita; H Takahashi; K Kakishita; A Yamamoto; T Yoshizaki; T Terashima; F Murakami; T Itakura; H Okano
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

4.  Generation of dopaminergic neurons in the adult brain from mesencephalic precursor cells labeled with a nestin-GFP transgene.

Authors:  K Sawamoto; N Nakao; K Kakishita; Y Ogawa; Y Toyama; A Yamamoto; M Yamaguchi; K Mori; S A Goldman; T Itakura; H Okano
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

5.  Brain repair by cell replacement and regeneration.

Authors:  Olle Lindvall; Ron McKay
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-16       Impact factor: 11.205

Review 6.  Genetic engineering of mesenchymal stem cells and its application in human disease therapy.

Authors:  Conrad P Hodgkinson; José A Gomez; Maria Mirotsou; Victor J Dzau
Journal:  Hum Gene Ther       Date:  2010-10-22       Impact factor: 5.695

7.  Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

Authors:  Rosa Canet-Aviles; Geoffrey P Lomax; Ellen G Feigal; Catherine Priest
Journal:  Stem Cells Transl Med       Date:  2014-08-22       Impact factor: 6.940

8.  Mesencephalic human neural progenitor cells transplanted into the neonatal hemiparkinsonian rat striatum differentiate into neurons and improve motor behaviour.

Authors:  Marine Hovakimyan; Stefan Jean-Pierre Haas; Oliver Schmitt; Bernd Gerber; Andreas Wree; Christian Andressen
Journal:  J Anat       Date:  2006-12       Impact factor: 2.610

9.  The promise of stem cells in Parkinson disease.

Authors:  J William Langston
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

10.  Factors influencing the differentiation of dopaminergic traits in transplanted neural stem cells.

Authors:  Ming Yang; Angela E Donaldson; Yubao Jiang; Lorraine Iacovitti
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.